Alto Neuroscience Inc.

ANRONYSE • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
18.26 USD
↘ 1.77 (8.84%)AT CLOSE (11:59 AM EDT)
18.20
↘ 0.06 (0.33%)
POST MARKET (AS OF 07:15 PM EDT)
Post Market
AS OF 07:15 PM EDT
18.20
↘ 0.06 (0.33%)
🔴Market: CLOSED
Open?$19.80
High?$20.21
Low?$17.95
Prev. Close?$20.03
Volume?414.1K
Avg. Volume?310.9K
VWAP?$18.71
Rel. Volume?1.33x
Bid / Ask
Bid?$18.21 × 100
Ask?$21.19 × 100
Spread?$2.98
Midpoint?$19.70
Valuation & Ratios
Market Cap?640.8M
Shares Out?35.1M
Float?23.9M
Float %?75.0%
P/E Ratio?N/A
P/B Ratio?2.63
EPS?-$2.12
Dividend?0.00%
Ex-Dividend?N/A

Alto Neuroscience Inc. (ANRO) trades at $18.26 per share. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
Themes
Biotech - Drug Development›Neuroscience & CNSHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
68
Market Cap
640.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.altoneuroscience.com
Listed
2024-02-02
Address
650 CASTRO STREET, SUITE 450
MOUNTAIN VIEW, CA 94041
Phone: 773-255-5012
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
69
Piotroski F-Score?0/9Weak
Altman Z-Score?10.72Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.73%Elevated
Short Interest?1.6M
Days to Cover?4.7
Free Float23.9M
Avg Daily Volume343.5K
Settlement Date2026-05-15
Financial Health
Current Ratio?20.52Strong
Quick Ratio?20.52Strong
Cash Ratio?20.11Strong
Debt/Equity?0.08Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
62
2.63CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-5.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
6
-30.5%WEAK▾
ROA?
S&P
3
-26.9%WEAK▾
Cash Flow & Enterprise
FCF?$-62860000
Enterprise Value?$395.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist